Kawan Renergy Berhad Q3 2024 Recorded 30.73% Gross Profit Margin
Kawan Renergy Berhad / KENERGY Q3 2024 financial quarterly report recorded 30.73% gross profit margin due. Some key developments in Q3 2024 for Kawan Renergy Berhad.
Clarity in Numbers, Confidence in Market Investment Decision
FinStatInsight bring financial statements to life, offering clear insights through company fundamentals analysis. Navigate the markets with confidence, leveraging our expertise for financial clarity and better investment strategies.
Latest Posts
See all posts
Feytech Holdings Berhad Q2 2024 Delivered Impressive Performance
Feytech Holdings Berhad, a leading manufacturer of automotive seats and covers in Malaysia, has announced strong financial results for the second quarter ended 30 June 2024. The company's revenue and profitability continue to be driven by the expansion of its manufacturing operations and the robust demand for its products.
Southern Cable Group Berhad Q1 2024 Profit Surge To 18.57 Million
Southern Cable Group Berhad Q1 2024 financial quarterly report recorded 18.57 Million profit before tax, almost 3 times compare to last year. The increase due to higher revenue growth due to sales volume of power cables and wires and adjusted average selling prices in line with raw material prices.
Jati Tinggi Group Berhad Q1 2024 Recorded 24.94% Net Profit Margin
Jati Tinggi Group Berhad Q1 2024 financial quarterly report recorded 24.94% net profit margin due to the gain on disposal of investment property (other income) of RM 7.24 million.
Mercury Securities Q4-2023 Profit Before Tax (PBT) Decline to RM 667K Amidst Listing Expenses Impacting RM 3.9M
Mercury Securities Q4-2024 concluding on October 31, 2023 profit before tax (PBT) down to 667k due to one off non-recurring listing expenses of RM 3.93 million. Without it, the Group would have recorded PBT of RM4.60 million.
Cengild Medical Berhad Q1 2024 Revenue 11% Growth vs Preceding Quarter.
Cengild Medical Berhad Q1 2024 concluding on September 30, 2023, achieved a revenue of RM17.60 million. This marks a notable growth of RM1.83 million, equivalent to 11.62%, when juxtaposed with the preceding quarter concluding on June 30, 2023, which reported revenue of RM15.77 million.
DC Healthcare Holdings Q3 2023 Financial Loss Due to Higher Administrative Expenses
DC Healthcare Holdings Berhad Q3-2023 interim financial report showing loss with higher administration expenses in this quarter amounting RM9.15 million. The substantial administrative expenses included one-off non-recurring listing expenses and consultancy fees related to the IPO exercise, amounting to RM3.85 million for the quarter under review.
